{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:13:27Z","timestamp":1792088007391,"version":"4.4.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A paucity of data exists regarding the natural history and outcome measures of adenosquamous carcinoma of the pancreas (ASCP), a histology distinct from pancreatic adenocarcinoma (PDAC). The aim of this study is to characterize the clinicopathological features of ASCP in a large cohort of patients comparing outcome measures of surgically resected patients to PDAC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We identified patients diagnosed with ASCP or PDAC from the National Cancer Database from 2004 to 2012. Patient demographics, tumor characteristics, treatment regimens, and overall survival were analyzed between the groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 207\u2009073 patients: 205\u2009328 (99%) in the PDAC group and 1745 (1%) in the ASCP group. ASCP tumors were larger, located more frequently in a body\/tail location (36% vs 24%, <jats:italic>P\u2009<\/jats:italic>&lt;\u20090.001), undifferentiated\/anaplastic histology (41% vs 17%, <jats:italic>P\u2009<\/jats:italic>&lt;\u20090.001), and early stage presentation, (39% vs 32%, <jats:italic>P\u2009<\/jats:italic>&lt;\u20090.001). There was no significant difference in OS when comparing all patients with PDAC and ASCP (6.2 months and 5.7 months, <jats:italic>P\u2009<\/jats:italic>=\u20090.601). In surgical patients ASCP histology was associated with worse OS (14.8 months vs 20.5 months, <jats:italic>P\u2009<\/jats:italic>&lt;\u20090.001) but had lower nodal involvement (55% vs 61%, <jats:italic>P\u2009<\/jats:italic>&lt;\u20090.001). ASCP histology was independently associated with worse OS, after adjusting for tumor characteristics, treatment, and patient demographics. In patients with only resected ASCP histology, negative lymph node status, R0 surgical resection, and receipt of chemotherapy was independently associated with improved overall survival following surgical resection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although patients with ASCP and PDAC tumors have similar survival when non\u2010surgical and surgical patients are combined, ASCP is associated with worse survival in stage I\/II resected patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jso.25112","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T14:11:26Z","timestamp":1528380686000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database"],"prefix":"10.1002","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-0839","authenticated-orcid":false,"given":"Caitlin A.","family":"Hester","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew M.","family":"Augustine","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Choti","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Mansour","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Minter","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio M.","family":"Polanco","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"},{"name":"Department of Veterans Affairs North Texas Health Care System Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Porembka","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam C.","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Yopp","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21387"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","unstructured":"McGuireS. World Cancer Report 2014. Geneva Switzerland: World Health Organization International Agency for Research on Cancer WHO Press 2015.Adv Nutr. 2016;7:418\u20139.","DOI":"10.3945\/an.116.012211"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.134.6.599"},{"key":"e_1_2_8_5_1","unstructured":"Armed Forces Institute of Pathology (U.S.) National Research Council (U.S.). Subcommittee on Oncology. Atlas of tumor pathology. Washington Armed Forces Institute of Pathology."},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2009.07.012"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-3-41"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-2-9129"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-007-1258-x"},{"key":"e_1_2_8_10_1","first-page":"330","article-title":"Adenosquamous carcinoma of the pancreas with clear cell and rhabdoid components A case report","volume":"8","author":"Jamali M","year":"2007","journal-title":"JOP"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.025221"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1270-0"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1226-4"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1385\/IJGC:29:1:53"},{"key":"e_1_2_8_15_1","first-page":"323","article-title":"Pancreatobiliary adenosquamous carcinoma (report of two cases)","volume":"92","author":"Yavuz E","year":"2000","journal-title":"Pathologica"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002610000059"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02781735"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00299.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000332185"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(98)70230-5"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03164758"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199702)64:2<159::AID-JSO13>3.0.CO;2-1"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02349652"},{"key":"e_1_2_8_24_1","first-page":"2739","article-title":"Response of adenosquamous carcinoma of the pancreas to interferon\u2010alpha, tumor necrosis factor\u2010alpha and 5\u2010fluorouracil combined treatment","volume":"14","author":"Tanaka N","year":"1994","journal-title":"Anticancer Res"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-6-95"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2008.03.027"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11855"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880332"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930490114"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930470210"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2011.06.015"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-010-1378-5"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.6765"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.15"},{"key":"e_1_2_8_35_1","unstructured":"American College of Surgeons: National cancer database. 1996\u20132017. (Accessed September 7 2017 athttps:\/\/www.facs.org\/quality-programs\/cancer\/ncdb)."},{"key":"e_1_2_8_36_1","volume-title":"International classification of diseases for oncology (ICD\u2010O)","author":"Fritz A","year":"2000"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0131"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0134"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-017-3544-5"},{"key":"e_1_2_8_40_1","first-page":"115","article-title":"Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas","volume":"6","author":"Wild AT","year":"2015","journal-title":"J Gastrointest Oncol"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.25112","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.25112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T07:18:34Z","timestamp":1694330314000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.25112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1002\/jso.25112"],"URL":"https:\/\/doi.org\/10.1002\/jso.25112","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"2018-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}